Skip to content

The Psychobiology of Posttraumatic Stress Disorder: Assessing psychological and biological parameters in healthy controls.

The Psychobiology of Posttraumatic Stress Disorder: Assessing psychological and biological parameters in healthy controls. - PBPTSD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON29944
Enrollment
100
Registered
2006-10-12
Start date
2004-01-10
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

posttraumatic stress syndrom PTSD

Interventions

Subjects will take an oral dose of 0.5 mg. dexamethasone once.

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Age: 25-65

Exclusion criteria

Exclusion criteria: -Any current or lifetime psychiatric disorder (as defined by DSM-IV criteria) determined by SCID-I. -Chronic diseases such as diabetes mellitus of any type, hypertension, hyperlipidemias, angina pectoris, myocardial and cerebral infarction, cerebral hemorrhage-stroke, and malignancy.

Design outcomes

Primary

MeasureTime frame
1. To investigate relations between PTSD and the psychological parameters relevant to: a) basic personality traits (Big Five) b) behavioral disintegration c) memory performance d) psychiatric symptoms 2. To investigate relations between PTSD and the biological parameters relevant to: a) anthropometric status b) metabolic status c) HPA axis function d) endogenous opiate system e) sleep disturbances 3. To investigate relations among the above mentioned biological and psychological parame-ters in health and PTSD 4. Designing of combined psycho-biological batteries for PTSD screening, diagnosing and risk factors assessing 5. Improvement of psychological instruments for measuring PTSD 6. Implementation of new biological markers for PTSD 7. Recommendation for improvement of combined psycho- and pharmacothe¬rapy of PTSD.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)